Observer of the Board
Rahul Singhvi is a recognized business leader with over twenty years of experience in vaccine development and manufacturing. He has held numerous leadership positions, including President and CEO of Novavax, a Nasdaq-listed vaccine development company, and Director of Manufacturing division at Merck & Co. As COO of Takeda’s Global Vaccine Business Unit, he is responsible for the global supply of Takeda vaccines, and was instrumental in the development and maintenance of the strategic partnership with Univercells and he now shares his strong expertise in vaccine development and manufacturing. Dr. Singhvi graduated as the top ranked chemical engineer from IIT, Kanpur, India and obtained both his MS and ScD chemical engineering degrees from MIT. He received an MBA degree from the Wharton School of the University of Pennsylvania, where he graduated as a Palmer Scholar.